Novartis AG, the Swiss drug maker whose U.S. affiliate is in East Hanover, will cut more jobs and eliminate some management posts because of rising competition and tougher regulation of the pharmaceuticals industry.
The maker of the Diovan heart medicine will reduce the number of management levels and re-evaluate the use of outside companies to conduct drug tests, spokesman John Gilardi said Tuesday. The Wall Street Journal reported the changes earlier in the day, citing Chief Executive Officer Daniel Vasella.
The moves follow a round of job cuts announced by the Basel-based company in October. Novartis has more than 11,000 employees in New Jersey and New York.
-- Bloomberg News
Going the way of Roche soon perhaps..?
That's why they've no SHAC demos outside their buildings.
Comments
Display the following comment